Business

Life sciences firm Reacta Healthcare investing in second facility on back of major export growth

Published

on


The expansion has been driven by exports, which currently account for 100% of revenues.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version